Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Sustainability Reports
The company operates as a comprehensive pharmaceutical research and development service platform in China. It provides drug research and development services, pharmaceutical research, clinical research, and CRO/CDMO services for innovative drugs and high-end generic drugs.
Sector: Professional & technical services
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG00Y73Z5W6
2 reports from 2022 to 2023
